MicroRNA-324-3p inhibits osteosarcoma progression by suppressing PGAM1-mediated aerobic glycolysis

Cancer Sci. 2023 Jun;114(6):2345-2359. doi: 10.1111/cas.15779. Epub 2023 Mar 21.

Abstract

Osteosarcoma (OS) is the most common primary malignant neoplasm of the bone. Recent studies have indicated that the inhibitory effects of microRNA (miR)-324-3p could affect the development of numerous cancers. However, its biological roles and underlying mechanisms in OS progression remain unexplored. In this study, miR-324-3p expression was markedly reduced in OS cell lines and tissues. Functionally, miR-324-3p overexpression suppressed OS progression and was involved in the Warburg effect. Mechanistically, miR-324-3p negatively regulated phosphoglycerate mutase 1 (PGAM1) expression by targeting its 3'-UTR. Moreover, high expression of PGAM1 promoted OS progression and aerobic glycolysis, which were associated with inferior overall survival in patients with OS. Notably, the tumor suppressor functions of miR-324-3p were partially recovered by PGAM1 overexpression. In summary, the miR-324-3p/PGAM1 axis plays an important role in regulating OS progression by controlling the Warburg effect. Our results provide mechanistic insights into the function of miR-324-3p in glucose metabolism and subsequently on the progression of OS. Targeting the miR-324-3p/PGAM1 axis could be a promising molecular strategy for the treatment of OS.

Keywords: PGAM1; Warburg effect; miR-324-3p; osteosarcoma; therapeutic target.

MeSH terms

  • Bone Neoplasms* / pathology
  • Cell Line, Tumor
  • Cell Proliferation / genetics
  • Gene Expression Regulation, Neoplastic
  • Glycolysis / genetics
  • Humans
  • MicroRNAs* / metabolism
  • Osteosarcoma* / pathology
  • Phosphoglycerate Mutase / genetics
  • Phosphoglycerate Mutase / metabolism

Substances

  • MicroRNAs
  • MIRN324 microRNA, human
  • Phosphoglycerate Mutase
  • phosphoglycerate mutase 1, human